Magda Marquet
CIK: 0001631486
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
Exercise(M)Direct6K shares- - Jun 5, 2026ARCT
Arcturus Therapeutics Holdings Inc.
Award(A)DirectStock option (right to buy)
15K shares- - May 22, 2026IMMX
Immix Biopharma, Inc.
Award(A)Direct6.3K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
42K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
15K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
4K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
5.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
784 shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
11K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
9.2K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
10.6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.5K shares- - Jan 15, 2026ANAB
ANAPTYSBIO, INC
Exercise(M)Direct11K shares at avg. $26.11$287K - Jan 15, 2026ANAB
ANAPTYSBIO, INC
Sale(S)Direct1.7K shares at avg. $48.85$84K - Jan 15, 2026ANAB
ANAPTYSBIO, INC
Sale(S)Direct9.3K shares at avg. $48.12$447K - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
5.5K shares- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectRestricted Stock Unit
4K shares- - Jun 20, 2025IMMX
Immix Biopharma, Inc.
Award(A)DirectStock Option (Right to Buy)
33K shares- - Jun 15, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct6K shares- - Jun 9, 2025ARCT
Arcturus Therapeutics Holdings Inc.
Award(A)DirectStock option (right to buy)
15K shares- - Jan 7, 2025ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
16.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise(M) | 6,030 | - | $0 | Direct |
| Jun 5, 2026 |  ARCT Arcturus Therapeutics Holdings Inc. | Award(A) Stock option (right to buy) | 15,000 | - | - | Direct |
| May 22, 2026 |  IMMX Immix Biopharma, Inc. | Award(A) | 6,250 | - | $0 | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 42,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 15,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 4,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 5,500 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 6,030 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 784 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 11,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 9,200 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 10,600 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Jan 15, 2026 |  ANAB ANAPTYSBIO, INC | Exercise(M) | 11,000 | $26.11 | $287,210 | Direct |
| Jan 15, 2026 | ANAB ANAPTYSBIO, INC | Sale(S) | 1,710 | $48.85 | $83,532 | Direct |
| Jan 15, 2026 | ANAB ANAPTYSBIO, INC | Sale(S) | 9,290 | $48.12 | $446,999 | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 5,500 | - | - | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Award(A) Restricted Stock Unit | 4,000 | - | - | Direct |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | Award(A) Stock Option (Right to Buy) | 33,000 | - | - | Direct |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 6,030 | - | - | Direct |
| Jun 9, 2025 | ARCT Arcturus Therapeutics Holdings Inc. | Award(A) Stock option (right to buy) | 15,000 | - | - | Direct |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
1-25 of 26 transactions
About Marquet Magda
Marquet Magda (SEC CIK 0001631486) files insider reports with the SEC as Director of First Tracks Biotherapeutics, Inc. (TRAX), Director of Arcturus Therapeutics Holdings Inc. (ARCT) and Director of Immix Biopharma, Inc. (IMMX). Signal8 also holds filings tied to 1 other company.
Signal8 holds 13 ownership filings by Marquet Magda (1 Form 3, 12 Form 4), filed between Jan 7, 2025 and Jun 17, 2026. Those filings report 26 transactions, from Jan 7, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Marquet Magda's filings is in SAN DIEGO, CA.
Recent filings by Marquet Magda
- Jun 15, 2026: Option exercise of TRAX shares (Form 4, code M).
- Jun 5, 2026: Grant or award of ARCT derivative securities (Form 4, code A).
- May 22, 2026: Grant or award of IMMX shares (Form 4, code A).
- May 12, 2026: Grants or awards of TRAX derivative securities (4 lines, Form 4, code A).
- Apr 20, 2026: Grants or awards of TRAX derivative securities (9 lines, Form 4, code A).
Other insiders filing for First Tracks Biotherapeutics, Inc. (TRAX)
- Orwin John A, Director
- Ware J. Anthony, Director
- STONE BENJAMIN, Chief Business Officer
- Lizzul Paul F., Chief Medical Officer
- Faga Daniel, President, CEO
- Jain Rita, Director